GHK Pharmaceuticals Private Limited
About GHK Pharmaceuticals Private Limited
Data last updated:
GHK Pharmaceuticals Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 23 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U21002UR2019PTC010342. Its GSTIN is 05AAICG0447N1ZG (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Silky Kumar and Piyush Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dehradun, Uttarakhand.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.78 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹64,027 (net margin 1.3%) and EBITDA of ₹95,716 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 141% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
Company details
CIN history
GHK Pharmaceuticals has one previous CIN (Corporate Identification Number): U24290UR2019PTC010342. The current CIN is U21002UR2019PTC010342, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21002UR2019PTC010342 | Current |
| U24290UR2019PTC010342 | Previous |
Contact details
GHK Pharmaceuticals Private Limited's registered office is in Dehradun, Uttarakhand.
- Registered AddressFh 02 402 N Terrace Gtm Forest & Hills Besides Aerodine Restaurant Mohkampur K, Hurd, Dehradun, Uttarakhand, India – 248005
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of GHK Pharmaceuticals Private Limited
FY 2025 filings availableGHK Pharmaceuticals Private Limited reported revenue of ₹50.78 Lakh (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 141% over five years, including 15% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹95,716 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹64,027 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of GHK Pharmaceuticals Private Limited, buy the company report.
Board of directors of GHK Pharmaceuticals Private Limited
GHK Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Silky Kumar Also directs: Adhyan Herbs Private Limited | Director | 23 Oct 2019 | 7 Years 0 Months | Current |
| Piyush Gupta Also directs: Adhyan Herbs Private Limited | Director | 29 Feb 2024 | 2 Years 7 Months | Current |
Peer comparison
GHK Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zenizen Pharmaceuticals Private Limited | ₹50.83 Lakh (FY 2024) | 12.0% | Jamshedpur, Jharkhand, India | |||
| Markecho Pharmaceuticals Private Limited | ₹50.83 Lakh (FY 2024) | 17.0% | Andheri, Mumbai, Maharashtra, India | |||
| Gallium Pharmaceuticals Private Limited | ₹50.81 Lakh (FY 2025) | 8.0% | Nagpur, Maharashtra, India | |||
| Blismed Pharmaceuticals Private Limited | ₹50.79 Lakh (FY 2025) | -4.0% | Baddi, Himachal Pradesh, India | |||
| Lucidus Pharmaceuticals Private Limited | ₹50.78 Lakh (FY 2025) | 50.0% | Cuttack Sadar, Odisha, India | |||
| GHK Pharmaceuticals Private Limitedthis company | ₹50.78 Lakh (FY 2025) | ₹64,027 | 1.3% | 15.0% | Dehradun, Uttarakhand, India | |
| Afcus Pharmaceuticals (OPC) Private Limited | ₹50.74 Lakh (FY 2023) | 1003.0% | Chandigarh, India | |||
| Silver Salt Pharmaceuticals Private Limited | ₹50.67 Lakh (FY 2023) | 129.0% | Karnal, Haryana, India | |||
| Wyeth Pharmaceuticals India Private Limited | ₹50.63 Lakh (FY 2025) | 37.0% | Mumbai, Maharashtra, India | |||
| Lucan Pharmaceuticals Private Limited | ₹50.57 Lakh (FY 2023) | 114.0% | Delhi, India | |||
| Azott Pharmaceuticals Private Limited | ₹50.53 Lakh (FY 2021) | -30.0% | Saraikela, Jharkhand, India |
To see the full peer comparison of GHK Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Dec 2025 | 101232709 | Canara Bank | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
GHK Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Smithkline Beecham Limited | Disposed |
To see the full case history of GHK Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for GHK Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
GHK Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAICG0447N1ZG | Uttarakhand | Active | 24 Dec 2019 |
To see the full GST registrations and return filing status of GHK Pharmaceuticals Private Limited, buy the company report.
Recent activity
GHK Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Seema ceased to be Director on 06 Mar 2024.
Frequently asked questions
GHK Pharmaceuticals is an active private limited company based in Dehradun, Uttarakhand, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 23 October 2019 (7+ years old) and is registered under CIN U21002UR2019PTC010342.
GHK Pharmaceuticals has 2 current directors:
- Silky Kumar - Director
- Piyush Gupta - Director
The latest financial statements of GHK Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of GHK Pharmaceuticals is 05AAICG0447N1ZG, registered in Uttarakhand.
The CIN (Corporate Identification Number) of GHK Pharmaceuticals is U21002UR2019PTC010342. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
GHK Pharmaceuticals has 1 court case on record: 1 filed against it.
GHK Pharmaceuticals was incorporated on 23 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of GHK Pharmaceuticals by revenue are Zenizen Pharmaceuticals Private Limited, Markecho Pharmaceuticals Private Limited, Gallium Pharmaceuticals Private Limited, Blismed Pharmaceuticals Private Limited, Lucidus Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Seema ceased to be Director on 06 Mar 2024. Piyush Gupta was appointed as Director on 29 Feb 2024. Silky Kumar was appointed as Director on 23 Oct 2019.
The registered office of GHK Pharmaceuticals is at Fh 02 402 N Terrace Gtm Forest & Hills Besides Aerodine Restaurant Mohkampur K, Hurd, Dehradun, Uttarakhand, India – 248005.
GHK Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.